Peptide-Based Therapy in Lupus: Promising Data
Systemic lupus erythematosus (SLE) is a multisystem chronic inflammatory disease of multifactorial aetiology, characterized by inflammation and damage of various tissues and organs. Current treatments of the disease are mainly based on immunosuppressive drugs such as corticosteroids and cyclophosphamide. Although these treatments have reduced mortality and morbidity, they cause a non-specific immune suppression. To avoid these side effects, our efforts should focus on the development of alternative therapeutic strategies, which consist, for example in specific T cell targeting using autoantigen-derived peptides identified as sequences encompassing major epitopes.
KeywordsSystemic Lupus Erythematosus Lupus Nephritis Cell Epitope Lupus Patient P140 Peptide
Unable to display preview. Download preview PDF.
- Benkirane, N., Guichard, G., Briand, J.P. and Muller, S. (1996) Exploration of requirements for peptidomimetic immune recognition. Antigenic and immunogenic properties of reduced peptide bond pseudopeptide analogues of a histone hexapeptide. J. Biol. Chem. 271, 33218–33224.CrossRefPubMedGoogle Scholar
- Ben-Yedidia, T., Beignon, A.S., Partidos, C.D., Muller, S. and Arnon, R. (2002) A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. Mol. Immunol. 39, 323–331.CrossRefPubMedGoogle Scholar
- Dali, H., Busnel, O., Hoebeke, J., Bi, L., Decker, P., Briand, J.P., Baudy-Floc’h, M. and Muler, S. Heteroclitic properties of mixed-α -and aza-α 3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome. Mol. Immunol. 44, 3024–3036.Google Scholar
- Hahn, B.H., Singh, R.R., Wong, W.K., Tsao, B.P., Bulpitt, K. and Ebling, F.M. (2001) Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44, 432–441.CrossRefPubMedGoogle Scholar
- Monneaux, F., Briand, J.P. and Muller, S. (2000) B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4(+) T cells recognize a T cell epitope located within the RNP80 motif of the 70 K protein. Eur. J. Immunol. 30, 2191–2200.CrossRefPubMedGoogle Scholar
- Stemmer, C., Quesnel, A., Prévost-Blondel, A., Zimmermann, C., Muller, S., Briand, J.P. and Pircher, H. (1999) Protection against lymphocytic choriomeningitis virus infection induced by a reduced peptide bond analogue of the H-2Db-restricted CD8(+) T cell epitope GP33. J. Biol. Chem. 274, 5550–5556.CrossRefPubMedGoogle Scholar
- Toskos, G.C. (1999) Overview of cellular function in systemic lupus erytheatosus. In: Lahita R. (Ed), Systemic Lupus Erythematosus, 3rd ed., Academic Press, San Dego, pp. 17–54.Google Scholar